|Title||EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.|
|Journal||Current Cardiology Reports|
|Authors||Ouyang P, Gottlieb SH, Culotta VL, Navas-Acien A|
|Link to article|
|Link to abstract|
This review discusses the epidemiologic evidence and animal and human studies supporting the role of these metals in the development of diabetes and ischemic heart disease and potential ways by which EDTA chelation could confer cardiovascular benefit.